维普中文期刊产品整合服务
12篇 您的检索式:作者名="DAVIT BM"
    题名 作者 年代 出处 被引量
1Implementation of a reference-scaled average bioequivalence approach for highly vari- able generic drug products by the US Food and Drug Administra- tion显示文摘DAVIT BM CHEN ML CONNER DP 2012AAPS J2012,14,4:1
2Highly variable drugs: observations from bioequivalence data submitted to the FDA for new generic drug applications 显示文摘Davit BM Conner DP Fabian-Fritsch B 2008AAPS J2008,10,1:1
3Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration 显示文摘Davit BM Chen ML Conner DP 2012AAPS J2012,14,4:1
4Bioequivalence approaches for highly variable drugs and drugproducts 显示文摘Haidar SH Davit BM Chen ML 2008Pharm Res2008,25,1:1
5Implementation of a reference-scaled average bioequivalence approach for highly varia- ble generic drug products by the US Food and Drug Administra- tion显示文摘DAVIT BM CHEN ML CONNER DP 2012AAPS J2012,14,4:1
6Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration 显示文摘Davit BM Nwakama PE Buehler GJ 2009Center for Drug Evaluation and Research2009,43,10:1
7Implementation of a reference-scaled average bioequivalence approach for highly vari- able generic drug products by the US Food and Drug Administra- tion显示文摘DAVIT BM CHEN ML CONNER DP 2012AAPS J2012,14,4:1
8Survey of interna- tional regulatory bioequivalence recommendations for approval of generic topical dermatological drug products显示文摘BRADDY AC DAVIT BM STIER EM 2015AAPS J2015,17,1:1
9Highly varia- ble drugs:observations from bioequivalence data submitted to the FDA for new generic drug applications 显示文摘DAVIT BM CONNER DP FABIAN-FRITSCH B 2008J2008,10,1:1
10Highly variable drugs: observations from bioequivalence data submitted to the FDA for new generic drug applications 显示文摘DAVIT BM CONNER DP FABIAN-FR1TSCH B 2008AAPS J2008,10,1:1
11Implementation of a reference-scaled average bioequivalence approach for highly var- iable generic drug products by the US Food and Drug Administra- tion显示文摘DAVIT BM CHEN ML CONNER DP 2012AAPS J2012,14,4:1
12Implementation of a reference-scaled average bioequivalence approach for highly var- iable generic drug products by the US Food and Drug Administra- tion显示文摘DAVIT BM CHEN ML CONNER DP 2012AAPS J2012,14,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费